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Intrinsic resistance of oligodendrocytes to prion infection
Abstract
Within the CNS, the normal form of cellular prion protein (PrP(C)) is expressed on neurons,
oligodendrocytes, and astrocytes. The contribution of these cell types to prion replication and
pathogenesis is unclear. To assess the role of oligodendrocytes, we expressed PrP(C) under the control
of the myelin basic protein (MBP) promoter in mice lacking endogenous PrP(C). PrP(C) was detected in
oligodendrocytes and Schwann cells but not in neurons and astrocytes. MBP-PrP mice never developed
scrapie after intracerebral, intraperitoneal, or intraocular challenge with scrapie prions. Transgenic
brains did not contain protease-resistant prion protein and did not transmit scrapie when inoculated into
PrP(C)-overexpressing indicator mice. To investigate whether prion spread within the CNS depends on
oligodendrocytic PrP(C), we implanted PrP(C)-overexpressing neuroectodermal grafts into MBP-PrP
brains. After intraocular prion inoculation, none of the grafts showed spongiform encephalopathy or
prion infectivity. Hence oligodendrocytes do not support cell-autonomous prion replication,
establishment of subclinical disease, and neural spread of prions. Prion resistance sets oligodendrocytes
aside from both neurons and astrocytes.
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Within the CNS, the normal form of cellular prion protein (PrP C) is expressed on neurons, oligodendrocytes, and astrocytes. The
contribution of these cell types to prion replication and pathogenesis is unclear. To assess the role of oligodendrocytes, we expressed PrP C
under the control of the myelin basic protein (MBP) promoter in mice lacking endogenous PrP C. PrP C was detected in oligodendrocytes
and Schwann cells but not in neurons and astrocytes. MBP–PrP mice never developed scrapie after intracerebral, intraperitoneal, or
intraocular challenge with scrapie prions. Transgenic brains did not contain protease-resistant prion protein and did not transmit
scrapie when inoculated into PrP C-overexpressing indicator mice. To investigate whether prion spread within the CNS depends on
oligodendrocytic PrP C, we implanted PrP C-overexpressing neuroectodermal grafts into MBP–PrP brains. After intraocular prion inoc-
ulation, none of the grafts showed spongiform encephalopathy or prion infectivity. Hence oligodendrocytes do not support cell-
autonomous prion replication, establishment of subclinical disease, and neural spread of prions. Prion resistance sets oligodendrocytes
aside from both neurons and astrocytes.
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Introduction
Prion protein (PrP) plays a central role in the pathogenesis of
transmissible spongiform encephalopathies (TSEs) such as sheep
scrapie, bovine spongiform encephalopathy, and Creutzfeldt–
Jakob disease (Aguzzi and Weissmann, 1997; Aguzzi et al., 2001).
The normal form of PrP, designated PrP C, is encoded by the Prnp
gene (Basler et al., 1986), and is almost ubiquitously expressed. In
the CNS, PrP C is predominantly neuronal, but expression on
astrocytes and oligodendrocytes is also detectable (Moser et al.,
1995). Prnp o/o mice are devoid of PrP C and develop and behave
normally (Bu¨eler et al., 1992) but are resistant to prion disease
(Bu¨eler et al., 1993) and do not support replication of prions
(Sailer et al., 1994). Reintroduction of PrP transgenes into
Prnp o/o mice, even when carrying significant amino-proximal
deletions, restores susceptibility to scrapie (Fischer et al., 1996;
Shmerling et al., 1998; Flechsig et al., 2000).
Previous transgenetic studies have revealed that expression of
PrP C on either neurons or astrocytes is sufficient for scrapie rep-
lication (Race et al., 1995; Raeber et al., 1997). Surprisingly, mice
expressing PrP C only within astrocytes or only within neurons
develop indistinguishable pathologies after prion infection. Al-
though oligodendrocytes express PrP C and are histogenetically
highly related to astrocytes, it is not known whether they play a
role in prion replication and in development of brain damage.
White-matter involvement in TSEs was proposed to be a result of
direct modifications of oligodendrocyte physiology (El Hachimi
et al., 1998). If this is the case, oligodendrocytes may contribute to
the pathogenetic process of scrapie.
The mechanisms by which prions spread within the CNS are
unknown. Although neuronal trans-synaptic spread appears
plausible, expression of PrP C in myelinating cells and the alleged
potential of cultured Schwann cell lines to generate prion infec-
tivity during infection (Follet et al., 2002; Archer et al., 2004) raise
a possible role for oligodendrocyte-borne PrP C in the cerebral
spread of prions. The latter issue may be of practical interest,
because neuroinvasion can occur, for example, via the heavily
myelinated visual pathway after conjunctival instillation (Scott et
al., 1993), corneal grafts (Duffy et al., 1974), and intraocular in-
jection (Fraser, 1982).
These questions would be testable in animals that express
PrP C exclusively on myelinating cells. Expression would have to
be sustained and highly selective, with no other cells expressing
PrP C. Here we describe transgenic mice expressing PrP C under
the control of the myelin basic protein (MBP) promoter. PrP C
was strongly and exclusively expressed in oligodendrocytes and
Schwann cells, but not in neurons or astrocytes. Using this model,
we have established that expression of PrP C on myelinating cells
does not support prion replication or spread of the agent along
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neural pathways. These results are in contrast to previous evi-
dence that had been gathered with cultured cells and negate any
cell-autonomous role for myelinating cell-borne PrP C in the
pathogenesis of prion diseases.
Materials and Methods
DNA constructions and generation and identification of transgenic mice. A
blunt-ended 760 bp fragment containing the entire PrP open reading
frame (ORF) region (corresponding to exon 3 of the Prnp gene) (Fischer
et al., 1996) was introduced and ligated into the EcoRI restriction sites of
the MBP construct (see Fig. 1 A). The 1.3 kb promoter region of the
mouse MBP gene contains the cap site of MBP mRNA and 5 noncoding
sequences. Although the cDNA fragment used is only approximately
two-thirds as long as the normal MBP cDNA and does not contain se-
quences corresponding to the 3 portion of MBP mRNA, it contains the
full coding sequence of 14 kDa for the smallest mouse MBP. Poly(A)
addition signals are provided from rabbit -globin and simian virus 40
early genes, and the second intron of the rabbit -globin gene is placed
between the cap site and PrP ORF for splicing.
Plasmid DNA was digested with HindIII and SalI and microinjected
into homozygous Prnp o/o zygotes, as described previously (Fischer et al.,
1996). Using PCR, founders were identified by the presence of Prnp o
alleles and Prnp transgenes. The primers P3 (specific for the disrupted
Prnp allele), P10 (for the wild-type Prnp gene), and Mut217 (exon 3
primer) were used under standard PCR conditions (Fischer et al., 1996).
Transgenic founders were mated to Prnp o/o mice, and one transgenic
line, designated tg640/o, was established from the F1 progeny on a
Prnp o/o mixed background, C57BL/6  129Sv. Additional breeding
yielded the homozygous line tg640/, or MBP–PrP.
Northern blot analyses. Mouse-brain total RNA was isolated with
RNAeasy Midi kits (Qiagen, Hilden, Germany), and samples (15 g)
were electrophoresed through a 1% agarose gel in 0.02 M sodium borate,
pH 8.3, 0.5 mM EDTA, and 5% formaldehyde. RNA was blotted onto
Hybond-N membranes (DuPont, Billerica, MA) using 20 SSC and
cross-linked to membranes by ultraviolet radiation. Prehybridization oc-
curred for 4 hr at 42°C in 50% formamide, 1 M NaCl, 1% SDS, and 10%
dextran sulfate. Hybridization occurred overnight at 42°C in the same
buffer using 32P-labeled probe A (10 6 cpm/ml), prepared by random
priming, which is known to hybridize to transcripts produced by both
wild-type and disrupted Prnp genes (Bu¨eler et al., 1992), and 0.1 mg/ml
denatured salmon-sperm DNA. Membranes were washed for 10 min at
room temperature (RT) in 2 SSC, washed twice for 30 min at 60°C in
2 SSC and 1% SDS, and washed twice for 30 min at RT in 1 SSC.
Autoradiography was performed for 7–24 hr at RT using Eastman Kodak
(Rochester, NY) XAR-5 film and an intensifier screen.
Western blot analysis. Brain homogenates were adjusted to 5 mg/ml,
and 50g of total protein from each sample was electrophoresed through
a 12% SDS-PAGE gel. Proteins were transferred to nitrocellulose by semidry
blotting. Membranes were blocked with TBS–Tween 20 and 5% nonfat milk,
incubated with antibody 6H4 or POM1 (monoclonal antibody to PrP; M.
Polymenidou and A. Aguzzi, unpublished data), and developed by enhanced
chemiluminescence (Amersham Biosciences, Braunschweig, Germany), as
described recently (Prinz et al., 2002). Quantification was performed
using NIH Image software (http://rsb.info.nih.gov/nih-image/).
In situ hybridization. A 290 bp Asp718 –BstEII fragment of the mouse
PrP cDNA was cloned into pBluescript KS and SK vectors (Stratagene, La
Jolla, CA). Digoxygenin-labeled sense and antisense probes were synthe-
sized (Boehringer Mannheim, Mannheim, Germany) from Asp718-
cleaved KS and SK constructs, respectively, using T3 RNA polymerase
(Raeber et al., 1997). Sections were deparaffinized and postfixed in 4%
paraformaldehyde in PBS, RNA was denatured for 10 min in 0.1 M HCl,
and sections were digested with 10 g/ml proteinase K (PK) at 37°C for
10 min. After a second fixation step in 4% paraformaldehyde for 10 min,
acetylation was performed in 0.1 M triethanolamine and 0.25% acetic
anhydride, and prehybridization was performed in 5 SSC, 50% form-
amide, 5 Denhardt’s solution, and 50 g/ml yeast tRNA for 90 min at
room temperature. Hybridization was performed in the same mixture,
containing the digoxygenin-labeled probe (50 ng/ml; 12 hr; 58°C). Sam-
ples were washed for 1 hr at 65°C in 0.2 and 0.1 SSC, respectively,
labeled with anti-digoxigenin Fab fragments (1:5000), and developed
with 5-bromo-4-chloro-3-indolyl phosphate and 4-nitroblue tetrazo-
lium chloride. Sections were mounted in glycerol gelatin.
Transmission electron microscopy. White matter was freshly prepared
from mouse brains and fixed for 4 hr at 4°C in PBS containing 4%
formaldehyde and 0.1% glutaraldehyde. These small tissue fragments
were immersed in 2 M sucrose containing 15% polyvinyl pyrrolidone (10
kDa; Sigma, St. Louis, MO), mounted on aluminum pins, frozen, and
stored in liquid nitrogen. Grids with ultrathin sections [prepared accord-
ing to Tokuyasu (1976)] were conditioned with PBS containing 0.5%
milk powder and 0.02% Tween 20 for 10 min, incubated with PrP-
specific mouse IgG (10g/ml in conditioning buffer; clone 6H4; Prionics
AG, Schlieren, Switzerland) for 2 hr at room temperature, rinsed with
PBS, and incubated with 8 nm gold-labeled goat anti-mouse IgG (diluted
to an absorbance of 0.1 at 525 nm with conditioning buffer) for 1 hr.
After rinses with PBS and distilled water, grids were embedded and
stained with methylcellulose and uranyl acetate. Micrographs were taken
on a Zeiss (Oberkochen, Germany) EM 910 at an original magnification
of 20,000.
Preparation of oligodendrocytes and immunofluorescence. Optic nerve
oligodendrocytes were isolated from postnatal day 7– 8 wild-type, trans-
genic, and Prnp o/o mice, as described previously for the rat (Schwab and
Caroni, 1988). Four days after isolation, cells were fixed with 4% para-
formaldehyde and 5% sucrose in PBS for 15 min at RT. The cultures were
permeabilized and blocked in PBS supplemented with 0.1% Triton
X-100 and 10% FCS and then incubated with anti-myelin-associated
glycoprotein (MAG; 1:100; Roche Diagnostics , Rotkreuz, Switzerland)
and anti-PrP rabbit antiserum XN (1:800; raised against full-length mu-
rine PrP) for 1 hr at RT. After washing, the cells were incubated with goat
anti-mouse secondary antibodies conjugated with Alexa 488 (1:150; Mo-
lecular Probes, Eugene, OR) and goat anti-rabbit Alexa 546 (1:500). After
additional washing, stained cultures were embedded in Mowiol (Calbio-
chem, La Jolla, CA) and mounted on slides for fluorescence microscopy.
Scrapie infection and determination of infectivity. Mice were inoculated
intraperitoneally with 100l of brain homogenate containing 6 logLD50,
intracerebrally with 30 l (3 10 5 LD50) of the Rocky Mountain Labo-
ratory (RML) scrapie strain (passage 5), or intraocularly with 10 l (1
10 5 LD50) of the same RML scrapie strain, prepared as described previ-
ously (Bu¨eler et al., 1993). Mice were monitored every second day, and
scrapie was diagnosed according to standard clinical criteria. Mice were
killed on the day of onset of terminal clinical signs of scrapie. Infectivity
of tissues was determined on 1% spleen or brain homogenates. Tissues
were homogenized (10% w/v) in 320 mM sucrose with a microhomog-
enizer, passed several times through 18 and 22 gauge needles, and diluted
in PBS with 5% BSA. When the solution appeared homogenous, it was
spun for 5 min at 500  g. Supernatants (30 l) were inoculated intra-
cerebrally into groups of four tga20 mice (Fischer et al., 1996). Indicator
mice were killed after development of terminal scrapie and the relation-
ship y  11.45  0.088 x, where y is logLD50/ml homogenate and x is
incubation time in days to terminal disease, was used to calculate infec-
tivity titers (Prusiner et al., 1982). The presence of a protease-resistant
isoform of PrP (PrP Sc) in the infected brains was investigated on pro-
teinase K-treated (50g/ml; 30 min; 37°C) homogenates by Western blot
analysis, as described above.
Histoblots. Histoblots were performed as described previously
(Prusiner et al., 1982). Frozen brains that were cut into 12-m-thick
slices were mounted on nitrocellulose membranes. Total PrP, as well as
PrP Sc after digestion with 50 g/ml proteinase K for 4 hr at 37°C, were
detected with PrP antibody 6H4 (1:2000 in 1% nonfat milk, overnight at
4°C) and alkaline phosphatase immunoconjugates. Visualization was
performed using 5-bromo-4-chloro-3-indolyl phosphate and 4-nitroblue
tetrazolium chloride (Boehringer Mannheim).
Establishment and analysis of intracerebral neuronal grafts. Embryos
were obtained at day 12.5 after conception from homozygous matings of
tga20 transgenic mice and transferred into modified HBSS that was sup-
plemented with 10% FCS and 2% glucose at 4°C. The neuroectodermal
anlage was prepared, homogenized in a volume of 30l, and grafted into
the caudoputamen of adult wild-type mice, as described previously
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(Brandner et al., 1996a; Isenmann et al., 1996a,b). For histological anal-
ysis, mice were killed while under deep anesthesia. For paraffin histology,
whole mouse brains were fixed for at least 72 hr in 4% paraformaldehyde
and PBS and processed for paraffin embedding. Hematoxylin and eosin
staining and immunohistochemistry for GFAP (anti-GFAP antiserum;
1:300; Dako, High Wycombe, UK) and synaptophysin (synaptophysin
antiserum; 1:40; Dako) were all performed on sections of paraffin-
embedded tissues. Biotinylated secondary antibodies (goat anti-rabbit
and rabbit-anti mouse; Dako) were used at a 1:200 –1:300 dilution. Vi-
sualization was achieved using biotin–avidin–peroxidase (Dako) and
diaminobenzidine as a chromogen, according to the protocols suggested
by the manufacturer.
Results
MBP–PrP transgenic mice express PrP C exclusively on
myelinating cells
To drive expression of PrP C in myelinating cells, we prepared a
DNA construct in which the entire coding region of the murine
Prnp gene was placed under the transcriptional control of a mu-
rine MBP promoter fragment. A similar strategy has been used
for expressing myelin basic protein antisense transcripts to pro-
duce a shiverer-like hypomyelinating mouse model (Katsuki et
al., 1988). The construct, consisting of the 1.3 kb promoter region
of the mouse MBP gene and two 0.6 kb rabbit -globin introns
that flank the 0.76 kb PrP open reading frame region (Fig. 1A),
was excised from its prokaryotic backbone and injected into the
pronuclei of Prnp o/o zygotes.
Transgenic founders were identified by PCR analysis and
Southern blotting (Fig. 1B). Nine of 11 PCR-positive founder
(F0) mice transmitted the transgene to their offspring.
Transgene-carrying animals were bred to Prnp o/o mice. Trans-
gene expression in the resulting mouse colony (mixed C57BL/
6  129Sv) was analyzed in organs of 12-week-old F1 offspring.
Unless otherwise specified, all subsequent analyses were per-
formed with homozygous offspring of one line (designated
tg640) that showed sustained transcription of the transgene (Fig.
1C). Northern blot analysis failed to detect expression of the
transgene in spleen, kidney, thymus, liver, testes, lung, heart, and
muscle (data not shown).
We amplified and sequenced genomic DNA of six randomly
chosen mice, as well as RNA from brain samples of four randomly
chosen mice, after retrotranscription, with primers encompass-
ing the Prnp open reading frame, which is contained in one single
exon. We only detected sequences corresponding to the wild-type
Prnp open reading frame, thereby excluding mutations in the
transgene or RNA editing leading to a mutated protein (data not
shown).
We then assessed expression of PrP C by Western blot analysis.
Homogenates of whole tg640 brains, as well as of subregions
thereof, yielded a characteristic three-band pattern of unglycosy-
lated, monoglycosylated, and diglycosylated PrP (Fig. 1D,F).
Western blots of spleen, heart, lung, thymus, muscle, liver, and
kidney did not reveal any PrP C expression (data not shown).
Tg640 mice developed normally and remained healthy, without
any abnormal clinical signs, for670 d.
To quantitate total PrP levels in transgenic brains (Fig. 1D),
serial twofold dilutions of tg640 and wild-type brain homoge-
nates in Prnp o/o homogenates were blotted, and the relative ex-
pression levels were calculated from calibration curves obtained
by direct acquisition of chemiluminescence (Fig. 1E), as de-
scribed previously (Heppner et al., 2001). The PrP C content in
tg640 brains was35% of that found in wild-type mice. Immu-
noblotting of sciatic nerves of MBP–PrP, Prnp o/o, and Prnp/
mice (Fig. 1D) revealed expression of PrP C in sciatic nerves of
MBP–PrP mice. However, the amount of PrPC was only 7% of
that found in wild-type mice.
We then analyzed the details of intracerebral PrP C distribu-
tion in tg640 mice (Fig. 1F). Western blot analysis of anatomi-
cally dissected cortical and subcortical forebrain compartments
indicated strong PrP C signals in the white matter (subcortex), yet
Figure 1. Generation and identification of MBP–PrP transgenic mice. A, Schematic drawing of the MBP–PrP transgene used for generation of transgenic mice. Arrows and parenthetical numbers
indicate the respective restriction sites. The second intron of rabbit-globin was placed between the cap site and MBP cDNA to improve transgene expression. mMBP, Mouse MBP; mPrnp, mouse
Prnp; SV40, simian virus 40. B, Genomic Southern blot analysis of MBP–PrP transgenic mice. EcoRI exactly excises the PrP ORF, confirming the presence of the transgene. (All tested mice showed the
same banding pattern.) The BglII and the BamHI–ClaI digestions verify the integrity of the 5 and 3ends, respectively. C, Northern blot analysis of brain RNA. The numbers above each lane indicate
the various transgenic lines analyzed. RNA from wild-type (Prnp/) and Prnp o/o brains was used as a control. D, PrP C expression in brains and sciatic nerves of hemizygous (hem) or homozygous
(hom) tg640 transgenic mice. Expression levels were estimated by comparison with serial twofold dilutions of wild-type brain homogenate. E, Brain PrP C quantification by chemiluminescence
analysis. The abscissa displays the amount of protein in micrograms; the ordinate shows chemiluminescence intensity (arbitrary units). F, Anatomical dissection of the CNS in the cerebellum,
brainstem, spinal cord, olfactory bulb, and gray or white matter (cortex, subcortex) revealed strongest expression of PrP C in white-matter or white-matter-rich regions of the CNS. MBP–PrP mice
display a dominant unglycosylated PrP C band, whereas wild-type mice show a dominant diglycosylated band. To facilitate sample comparisons, only 25% of total protein was loaded in wild-type
samples, resulting in PrP C bands of similar intensity. The uppermost bands represent actin. WT, Wild type.
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no PrP C was detected in the gray matter (cortex). Instead, in
wild-type (Prnp/) mice, both compartments contained size-
able levels of PrP C (data not shown). MBP–PrP mice displayed a
predominant unglycosylated PrP C band, whereas wild-type mice
show a dominant diglycosylated band, suggesting that post-
translational processing of PrP C differs between oligodendro-
cytes and other CNS cells.
We performed in situ hybridizations on brain and sciatic
nerve sections with digoxigenin-labeled riboprobes for PrP
mRNA (Fig. 2). In Prnp/ mice, PrP mRNA was found mainly
in neuronal cell bodies but was not detectable in glial cell bodies
within fiber tracts, such as in the corpus callosum (Fig. 2A). No
Prnp transcripts were detected in the corpus callosum of Prnp o/o
mice (Fig. 2B). In contrast, strong mRNA signals were observed
in the corpus callosum and, to a lesser extent, in the cerebral
cortex (data not shown) of adult tg640 brains, indicative of strong
PrP expression in oligodendrocytes (Fig. 2C). Control hybridiza-
tion with digoxigenin-labeled sense transcripts did not yield any
signal (Fig. 2D–F). In situ hybridizations of sciatic nerves yielded
PrP signals in both Prnp/ (tga20) and MBP–PrP mice but not
in Prnp o/o mice (Fig. 2 J–L). Hybridization signal intensity was
less prominent in MBP–PrP mice than in wild-type mice, which
is in line with the weaker protein expression. Again, sense probes
did not hybridize (data not shown).
Oligodendrocyte-restricted expression of
the PrP transgene in brains of tg640 mice
was demonstrated by colocalization of
mRNA for Prnp and the oligodendrocyte-
specific proteolipid protein (PLP) (Fig.
2G–I).
Transmission electron microscopy was
used to trace the subcellular distribution of
PrP C within the white matter of adult mice
(Fig. 3A–C). Punctuate distribution of col-
loidal gold-labeled antibodies to PrP C (ar-
rows) was found in axons as well as in sur-
rounding myelin sheaths of wild-type
mice (Fig. 3A), whereas only occasional
randomly distributed gold particles were
found in Prnp o/o mice. In contrast, tg640
mice displayed the largest number of gold
particles within myelinating oligodendro-
cyte processes (Fig. 3C).
Expression of PrP was also studied by
fluorescence microscopy in optic nerve ex-
plants from 7- to 8-d-old mice. Strong
PrP C labeling was observed only in oligo-
dendrocytes derived from tg640 mice, but
not from Prnp/ or Prnp o/o mice (Fig.
3D–F , top row). Costaining with the early
oligodendrocyte marker MAG (Fig. 3D–F,
bottom row) confirmed the assignment of
signals to oligodendrocytes, as well as the
purity of the cultured cells. The majority
(but not all) of MAG-cultured cells also
expressed PrP C. Thus, only more mature
cells that had formed membrane sheets be-
tween their processes were PrP positive,
which correlates with late MBP expres-
sion. Ectopic PrP expression did not affect
oligodendrocyte density, morphology, or
MAG expression.
Resistance of tg640 mice to scrapie
To test whether oligodendrocyte-restricted expression of PrP C
suffices to render Prnp o/o mice susceptible to scrapie, tg640 mice
were challenged with scrapie prions (RML strain, passage 5) in-
tracerebrally, intraperitoneally, or intraocularly. However, chal-
lenge of homozygous (intraperitoneally, n 12; intracerebrally,
n  10; intraocularly, n  7) or hemizygous (intraperitoneally,
n 11; intracerebrally, n 10; intraocularly, n 6) tg640 mice
and, as a control, Prnp o/o mice (intraperitoneally, n 4; intrace-
rebrally, n 5) did not result in clinical signs of scrapie in any of
the mice as late as 641 d postinoculation (dpi). This period of
time approaches the natural life span of laboratory mice. Instead,
wild-type mice that had been challenged with an inoculum of the
same size died of scrapie at 195 3 d after intraperitoneal (n
6), 163  4 d after intracerebral (n  6), and 194  11 d after
intraocular (n  7) inoculation (Table 1). All of these mice de-
veloped typical clinical symptoms of scrapie, such as ataxia, pa-
ralysis, kyphosis, foot-clasp reflex, and mincing gait. Thus, ex-
pression of full-length PrP C by oligodendrocytes of Prnp o/o mice
does not restore clinical susceptibility to scrapie.
A major hallmark of TSE diseases is brain deposition of PrP Sc
(McKinley et al., 1983). We assessed formation of PrP Sc in
scrapie-infected MBP–PrP mice by Western blot analysis of brain
Figure 2. Localization of PrP mRNA in MBP–PrP transgenic mice. In situ hybridization of forebrain sections ( A–I) with corpus
callosum and of sciatic nerve sections ( J–L) of adult Prnp/, Prnp o/o, and MBP–PrP transgenic mice is shown. Expression of PrP
mRNA occurs in neurons of wild-type (Prnp/) forebrains ( A) and in Prnp/ Schwann cells ( J), whereas Prnp o/o brains ( B)
and nerves ( K) lack any signal. In contrast, strong PrP signals are visible in callosal oligodendrocytes ( C) and sciatic Schwann cells
( I–L) of transgenic mice. D–F, Sense probes did not reveal any signals in brains and sciatic nerves. G–I, The oligodendrocyte-
specific PLP antisense probe revealed strong mRNA signals in the forebrains of all genotypes investigated. Scale bars, 50m.
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extracts (Fig. 4A). Terminally scrapie-sick, intracerebrally
scrapie-inoculated wild-type mice (Prnp/) showed high levels
of PrP Sc. However, clinically asymptomatic hemizygous tg640
mice killed 210 d after intracerebral inoculation did not exhibit
any detectable PrP Sc in their brains. All brains of scrapie-
inoculated mice surviving until termination of the experiments
(641 d postinoculation) were analyzed by histology. This analysis
failed to indicate any morphological signs of scrapie, such as
spongiosis or gliosis (data not shown).
Next, we investigated whether myelin-derived PrP C is re-
quired for the accumulation of PrP Sc in situ by histoblotting.
Mice were killed at the indicated time points and analyzed for the
presence of disease-associated PrP Sc (Fig. 4B). Large amounts of
proteinase K-resistant prion protein were found in infected
Prnp/ mice, whereas MBP–PrP and Prnp o/o mice lacked any
detectable PK-resistant PrP Sc. As reported previously (Brandner
et al., 1996a), myelinated structures show faint homogeneous
background staining in inoculated Prnp o/o mice. However, these
myelinated structures were much less intensive than the PrP C-
containing white-matter tracts in MBP–PrP mice.
To determine whether scrapie infectivity might subclinically
propagate in brains or spleens of asymptomatic tg640 mice, tissue
homogenates from animals killed at various time points were
injected intracerebrally into indicator tga20 mice (Fischer et al.,
1996), which overexpress Prnp under transcriptional control of
orthologous regulatory elements (Table 2). Brain homogenates
of Prnp/ mice 140 d after intraperitoneal inoculation or 167 d
after intracerebral inoculation elicited disease in tga20 mice after
58 –71 d. This result was compared with a calibration curve and
found to correspond to a prion titer of 4.9 – 6.3 logLD50. In
contrast, brains of tg640 transgenic mice never induced scrapie
after transmission to tga20 mice. We conclude that tg640 brains
do not replicate prion infectivity despite PrP C expression in oli-
godendrocytes. The detection threshold of the mouse bioassay
with tga20 mice under the conditions used here is1.5 logLD50
per gram of tissue.
Low levels of scrapie infectivity were detected in one spleen of
a tg640 mouse killed 35 d after intraperitoneal inoculation,
whereas three of four recipient tga20 mice died. This finding is
most likely a result of the presence of residual inoculum in this
investigated tg640 mouse. Similar findings have long been known
to occur, even after inoculation of PrP C-deficient mice (Bu¨eler et
al., 1993; Sailer et al., 1994). Neuropathological investigations of
brains from clinically sick wild-type mice revealed typical signs of
scrapie (e.g., spongiform changes and pronounced astrogliosis
predominantly in the neocortex and hippocampus; data not
shown). In contrast, no typical histopathological signs of scrapie
were visible in any of the examined clinically healthy tg640 mice
(n  9; killed at 641 dpi; data not shown). These observations
virtually exclude the possibility that scrapie prions replicate sub-
clinically in MBP–PrP mice.
Oligodendrocyte-borne PrP C does not support oculocerebral
prion spread
Intraocular prion inoculation leads to progressive scrapie pathol-
ogy along the optic nerve and optic tract to the contralateral
superior colliculus and lateral geniculate nucleus, followed by
generalized encephalopathy (Fraser, 1982; Brandner et al.,
1996b). These results suggest that the infectious agent travels
along fiber tracts of the CNS, such as the retinotectal projection.
To determine whether oligodendrocyte-restricted PrP C is suf-
Figure 3. Localization of PrP C in MBP–PrP mice. A–C, Cellular distribution of PrP C within the
white matter of adult mice revealed by immunoelectron microscopy of gold-labeled anti-PrP
antibody. Arrows indicate the location of the black gold particles. MBP–PrP mice display abun-
dant decoration of myelin with gold particles. Scale bar, 5 nm. D–F, Immunofluorescence of
primary optic nerve oligodendrocytes cultured from 7- to 8-d-old mice. Top row, expression of
PrP is detectable only in transgenic oligodendrocytes (F), whereas the early oligodendrocyte
marker MAG is expressed on all oligodendrocytes (bottom row). Scale bar, 5m.
Table 1. Resistance to scrapie of MBP-PrP mice
Type of prion challenge
(dose)
Mouse genotypes
MBP–PrP/o MBP–PrP/ Prnp/ Prnpo/o
Attack rate Disease latencya Attack rate Disease latencya Attack rate Disease latencya Attack rate Disease latencya
Intraperitoneal
(6 logLD50)
0/11 641 0/12 467 6/6 195 3 0/4 641
Intracerebral
(3 105 LD50)
0/10 641,
2210b
0/10 467,
1197b
6/6 163 4 0/5 467
1243b
Intraocular
(1 105 LD50)
0/6 531c 0/7 410,
1376d
7/7 194 11 ND
Only control wild-type mice (Prnp/) developed scrapie after intraperitoneal, intracerebral, and intraocular prion challenge, whereas mice carrying the MBP–PrP transgene hemizygously or homozygously and Prnp o/o mice never
developed clinical signs of scrapie. Average incubation times and SDs were calculated for the groups of mice that developed scrapie. For mice that remained free of disease, the total observation time is reported. All mice were bred to a similar
mixed genetic background (C57BL/6 129Sv). ND, Not determined.
aAverage SD.
bClinically healthy mice were killed at the time points indicated, and organs were used for infectivity analysis.
cOne mouse died 24 hr after inoculation.
dDeath of one mouse 376 d after inoculation resulting from abdominal tumor growth.
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ficient for centripetal scrapie spread, prions were inoculated in-
traocularly, intraperitoneally, and intracerebrally into either
tg640 or Prnp o/o mice containing a PrP-overexpressing tga20
neurograft (Fig. 5) (Brandner et al., 1996a). Prion injections were
performed62 d after transplantation to ensure full differentia-
tion of embryonic tissue into normal neuronal and glial compo-
nents and its integration into the host brain (Isenmann et al.,
1996a).
Tg640 or Prnp o/o mice grafted with tga20 neuroectoderm were
killed at247 dpi. By this time, all intracerebrally infected grafts
in both tg640 (n  8) and Prnp o/o (n  7) hosts had developed
severe scrapie encephalopathy, as diagnosed by the presence of
typical histopathological features, including spongiosis. Pro-
nounced gliosis typical of scrapie was visualized by immunocy-
tochemistry for GFAP, and synaptic loss was illustrated by coarse
granular deposits and patchy staining for synaptophysin. Pre-
dominantly synaptic deposits of PrP Sc were apparent with the
anti-PrP antibody SAF84. In contrast, none of nine tg640 and
four Prnp o/o mice that were inoculated intraocularly showed typ-
ical histopathological features of scrapie encephalopathy. Identi-
cal results were obtained with five intraperitoneally inoculated
tg640 and five Prnp o/o hosts. In two instances, brain grafts of
intraocularly inoculated tg640 mice were assayed by transmission
of tissue homogenates to groups of four tga20 mice. However,
none of the recipient mice developed disease, indicating that the
grafts were devoid of prion infectivity. We therefore exclude the
possibility that PrP C, when expressed solely on myelin compo-
nents, supports prion spread within the CNS.
Discussion
Spongiosis, neuronal loss, astroglial and microglial activation,
and accumulation of PrP Sc are the most prominent neuropatho-
logical features of TSEs. Although neurons are clearly affected in
the disease process, it is still unclear whether other brain cells also
play a role. Although it is undisputed that during the course of
prion diseases neurons can undergo pathological changes culmi-
nating in cell death, it is by no means clear whether neurons are
the sole or even the primary target of prions. Previous studies
have shown that astrocyte-specific expression of PrP driven by
the GFAP promoter is sufficient to mediate susceptibility to
scrapie in Prnp o/o mice (Raeber et al.,
1997) and, most surprisingly, to produce a
pathology similar to that of wild-type
mice. Furthermore, it was speculated that
oligodendrocytes may also participate in
scrapie pathogenesis, because PrP Sc accu-
mulated most strongly in the white-matter
areas, such as the corpus callosum or the
fiber tracts of the striatum, during scrapie
disease (Bendheim et al., 1992; Taraboulos
et al., 1992). In addition, substantial PrP
mRNA expression in the white-matter
tracts, as shown previously (Moser et al.,
1995), implied that oligodendrocytes
might be the primary producers of PrP Sc
and may be the primary target for prions as
well.
Here we describe transgenic mice
expressing full-length PrP C under the
control of the MBP promoter. The MBP
expression vector was shown to drive ex-
Figure 4. Absence of conversion of PrP C into PrP Sc after scrapie challenge of MBP–PrP mice. A, Western blots of homogenized
brain material electrophoresed natively () or after digestion with proteinase K (). Large amounts of PK-resistant prion protein
(PrP Sc) are detectable in brains of wild-type mice (Prnp/) that developed terminal scrapie 167 d postinoculation. No PrP Sc is
visible in Prnp o/o or MBP–PrP mice that had been challenged intracerebrally with a high dose of the RML strain. Molecular weight
markers are indicated on the left. B, Histoblot analysis of PrP Sc expression. Protease-resistant PrP was detectable only in intrace-
rebrally infected Prnp/mice. MBP–PrP and Prnp o/o mice did not accumulate PrP Sc. As reported previously (Brandner et al.,
1996b), myelinated structures show faint homogeneous background staining in inoculated Prnp o/o mice.
Table 2. Prion load in brains and spleens of individual tg640 mice
Mouse
genotypes
Days after inoculation;
route of infection
Transmission of brain to indicator mice Transmission of spleen to indicator mice
Brain infectivity
(logLD50 per gram)
Attack rate
(mean SD days)
Spleen infectivity
(logLD50 per gram)
Attack rate
(mean SD days)
MBP–PrP 35 d; intraperitoneal 	1.5 0/4 	1.5 0/4
	1.5 0/4 	1.5 3/4 (99,148,150)a
140 d; intraperitoneal 	1.5 0/4 	1.5 0/4
	1.5 0/4 	1.5 0/4
210 d; intracerebral 	1.5 0/4 	1.5 0/4
	1.5 0/3 	1.5 0/4
Prnp/ 35 d; intraperitoneal 	1.5 0/4 5.0 4/4 (73  5)
	1.5 0/4 5.1 4/4 (72  4)
140 d; intraperitoneal 5.3 4/4 (68  6) 4.0 3/3 (84  4)
4.9 4/4 (74  7) 5.1 4/4 (72  8)
167 d; intracerebral 6.3 4/4 (58  6) 5.1 4/4 (72  5)
6.1 4/4 (60  7) 5.3 4/4 (70  2)
Prnpo/o 42 d; intraperitoneal 	1.5 0/4 	1.5 0/4
	1.5 0/4 	1.5 1/4 (99)
Wild-type (Prnp/) and tg640 mice homozygous for the MBP–PrP transgenic cluster were inoculated intraperitoneally and intracerebrally and killed for analysis at the time points indicated.
aPrion disease in three of four tga20 indicator mice that had received spleen extracts from a 35 dpi-challenged tg640 mouse is most likely a result of prions persisting from the inoculum.
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pression of the smallest isotype of myelin
basic protein and cure the hypomyelinat-
ing mouse model shiverer (Kimura et al.,
1989). Only one of nine transgenic lines
expressed sustained levels of PrP C. Inher-
ent toxicity of the transgene is unlikely, be-
cause the incidence of transgene-positive
founder mice was normal and line tg640
exhibited undistorted Mendelian trans-
mission of the MBP–PrP transgene. The
relative inefficiency of expression may be
specific to the MBP–PrP minigene with a
coding exon of 1.3 kb flanked by two small
artificial introns. In tg640 mice, full-length
PrP C was found exclusively on oligoden-
drocytes and on Schwann cells but was ab-
sent from other tissues and cell types. Al-
though the constitutive level of PrP C in the
total brains of transgenic mice was only
30 –35% of that observed in the normal
mouse brain, PrP C protein was clearly
overexpressed on transgenic oligoden-
drocytes compared with wild-type
oligodendrocytes.
There was no evidence for PrP C expres-
sion in either neurons or astrocytes. If any
expression occurred, it would be under the
detection limit of the methods used. Per-
haps the strongest argument for the strict
specificity of expression in oligodendro-
cytes is that we could not detect replication of prions in trans-
genic mice, whereas we know from studies published previously
that even very low levels of expression in astrocytes or neurons
would restore cerebral prion replication (Bu¨eler et al., 1994; Race
et al., 1995; Raeber et al., 1997). Inoculation of tg640 mice with
scrapie prions by different routes did not induce clinical disease
or cerebral PrP Sc deposition. This was unexpected in view of the
proposed role of oligodendrocytes during disease, as described
above.
The fact that PrP C expression was genuinely restricted to oli-
godendrocytes allowed us to ask questions related to the spread of
prions within the CNS. Intraocular inoculation into Prnp o/o mice
carrying PrP C-overexpressing grafts did not provoke scrapie in
grafts, supporting the conjecture that lack of PrP C on cells be-
longing to the visual pathway prevents prion spread within the
CNS (Brandner et al., 1996b). However, it is unclear which mech-
anisms, be they axonal or nonaxonal, may be involved. Non-
neuronal cells, including oligodendrocytes in the CNS and
Schwann cells, may play a supportive or obligate role. Within the
framework of the prion-only hypothesis, one might hypothesize a
“domino” mechanism, by which incoming PrP Sc converts resi-
dent PrP C on the axolemmal or myelin surface, thereby spatially
propagating the infection (Aguzzi and Weissmann, 1997). In-
deed, one study showed that the velocity of neuronal prion spread
is extremely slow (Kimberlin et al., 1983) and may not follow the
canonical mechanisms of fast axonal transport. Additional find-
ings support nonaxonal transport mechanisms that result in peri-
axonal deposition of PrP Sc (Hainfellner and Budka, 1999; Glatzel
and Aguzzi, 2000).
In a neurograft paradigm, we find that oligodendrocyte-borne
PrP C does not support transfer of prion infectivity from the eye to
intracerebral compartments. Could the negative outcome of the
grafting experiment be caused by technical problems of grafting
or of intraocular inoculation? This is unlikely, because tga20 neu-
rografts are easily infectible via the optic route when implanted
into Prnp/o hosts, but not when grafted into Prnp o/o hosts
(Brandner et al., 1996b).
Our findings on the ineffective spread of prions along the
visual pathway of tg640 mice do not favor the nonaxonal theory.
The hypothesis that spread of prions occurs axonally rests mainly
on the demonstration of progressive spongiform changes along
the retinal pathway after intraocular infection (Fraser, 1982).
Within these experiments, the spread of scrapie pathology was
observed first in the contralateral superior colliculus followed by
the lateral geniculate nucleus and visual cortex.
The negative outcome of all prion-related tests prompted us
to verify that MBP–PrP mice express intact PrP C on myelinating
cells. Northern and Western blot analyses, as well as in situ hy-
bridization, confirmed correct transcription of the transgene and
translation into PrP-immunoreactive protein with the expected
molecular characteristics. Because prion replication may be com-
promised even by immunochemically silent point mutations, we
sequenced the integrated transgene from PCR-amplified
genomic DNA. Again, no deviations from the expected sequence
were identified. Finally, we verified MBP–PrP transcripts by se-
quencing reverse transcription-PCR amplification products
from brain homogenates. The results of the latter assay rule out
RNA editing, which might lead to expression of mutated proteins
despite correct genomic sequences.
We still do not know how prions propagate within the brain.
The current study excludes any oligodendrocytic contribution to
prion pathogenesis by a PrP C-dependent cell-autonomous
mechanism. It is still possible, however, that oligodendrocytic
PrP C modulates the speed of prion neuroinvasion in a non-cell-
autonomous manner, perhaps by transcellular “painting” of gly-
cosylphosphatidylinositol-linked proteins to adjacent axolem-
Figure 5. Oligodendrocytic PrP C does not support intraneural prion transport. Embryonal PrP-overexpressing tga20 neural
tissue was transplanted into Prnp o/o (left) or MBP–PrP (right) mice. Hosts were inoculated with scrapie prions intraocularly (i.o.),
intraperitoneally (i.p.), or intracerebrally (i.c.). Neuropathological signs of scrapie (gliosis visualized by overexpression of glial
fibrillary acid protein, synaptic loss shown by loss of synaptophysin, and deposition of PrP) were only visible in grafts with hosts
that had been inoculated intracerebrally. In contrast, neural grafts remained free of disease after intraocular or intraperitoneal
inoculation. The trauma deriving from transplantation procedure induced a slight gliosis in all grafts. HE, Hematoxylin and eosin.
Scale bars, 100m.
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mal surfaces. Conversely, other experiments suggest that PrP Sc of
neuronal origin is unlikely to disturb oligodendrocyte physiology
to a clinically significant degree (Mallucci et al., 2003). The mouse
model described here will make it possible to address this and
related questions in a direct way.
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